A detailed history of Central Valley Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Central Valley Advisors, LLC holds 3,395 shares of PFE stock, worth $96,791. This represents 0.11% of its overall portfolio holdings.

Number of Shares
3,395
Holding current value
$96,791
% of portfolio
0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

BUY
$25.26 - $29.6 $85,757 - $100,492
3,395 New
3,395 $268 Million
Q4 2023

Feb 09, 2024

BUY
$26.13 - $33.94 $192,133 - $249,560
7,353 New
7,353 $212 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Central Valley Advisors, LLC Portfolio

Follow Central Valley Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Central Valley Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Central Valley Advisors, LLC with notifications on news.